Real World Evidence Solutions Market Size 2020, Share, Growth, Trends, Drivers, Restraints, Opportunities, and Global Industry Analysis 2027


Published Date : Oct 2020
Category : Pharmaceutical & Healthcare
Report Id : ReportCrux 1509
Publisher Name : ReportCrux
Price : $2,999
No of Pages : 199

New Year Sale: Upto 25% Discount on Real World Evidence Solutions Market with COVID-19 Impact Analysis

Real World Evidence Solutions Market Size

The global Real World Evidence Solutions Market is estimated to grow from USD XX Million in 2019 to reach USD XX Million by 2027, at a CAGR of XX% during the forecast period from 2020-2027.

Real World Evidence Solutions Market - Global Industry Trends, Dynamics, Competitive Insights and Forecast Analysis, 2020 – 2027

Key Player’s Analysis:

The report provides key player analysis along with company revenue shares in order to give a broader overview of the market players in the Real World Evidence Solutions market. Major players in market are

IQVIA (US), International Business Machines Corporation (US), ICON (Ireland), PAREXEL (US), Pharmaceutical Product Development (US), Optum (US), Cognizant (US), Oracle (US), SAS (US), Syneos Health (US), Anthem (US), Clinigen Group (UK), Palantir Technologies (UK), and Flatiron Health (US).

among others.

Market Overview:

The market report covers a basic overview of the market from the industry perspective. This will help the reader to get a gist about different industry dimensions from a manufacturer’s view. The report divides the market into different sections and is comprised of market revenue (value) by segments.

The report provides market data from 2016 till 2027, wherein, 2016 to 2018 will be historic years, 2019 would be the base year and 2020 to 2027 will be forecast years. The report provides different statistics and figures and charts that will help analyze trends and global Real World Evidence Solutions market share along with its growth rate in different regions and countries.

Key players across the globe are profiled in the report along with its company landscaping. Product portfolio for each company, recent developments and company strategies are covered along with the company financials.

Economy Trends & Strategic Analysis:

Various drivers, restraints and opportunities in the Real World Evidence Solutions market are analyzed in detail in the report. Key drivers that make the overall market grow are discussed thoroughly, along with its impact on the sales of different product types. Report also features restraining factors that are likely to restrain the market growth. As well, different opportunities which will propel the market in future and bring new growth avenues for major market players are discussed in detail. This will help in understanding the overall dynamics prevailing in the historic as well as in coming years.

Apart from this, the report covers various collaborations, mergers and acquisitions, regional expansions, new product launches and product pipelines for the key players involved in the market.

Segmental and Geographic Analysis:

The report describes in detail market segmentation by dividing the market based on its Component, Therapeutic Area, End User and region and is analyzed from 2016 to 2027 by value and volume. All the segments are evaluated by taking into consideration the historic and future trends. All the segments with the dominating & fastest growing sub-segments and the factors responsible for the same are studied and are mentioned in the report.

Evident quantitative as well as qualitative insights about the segments are covered in the report along with forecast analysis of all the segments that expected to alter the market in the future are described in detail. The segmental analysis also highlights details about different aspects that will influence the market.

Market is divided regionally and by country level into North America (U.S. Canada & Rest of North America), Europe (U.K., Germany, France, Italy, Spain, Russia & Rest of Europe), Asia Pacific (China, Japan, India, Australia, Southeast Asia & Rest of Asia Pacific), Latin America (Brazil, Mexico & Rest of Latin America) and Middle East and Africa (Saudi Arabia, South Africa, UAE & Rest of Middle East and Africa).

The report gives the pursuer the complete idea and understanding of the market and the regional and country level value and volume scenario and essentials for the industry. Current market insights on the regional level are studied and centered while market estimation, thus giving the reader a specialized idea & plans, financial as well as recent market advancements globally.

Real World Evidence Solutions Market Segmentation

By Component

  • Dataset (Claims, Clinical, Pharmacy, Patient), Services

By Therapeutic Area

  • Oncology, Cardiovascular, Immunology

By End User

  • Pharmaceuticals, Medical Devices, Payers, Providers

By Region

  • North America
    • US
    • Canada
    • Rest of North America
  • Europe
    • UK
    • Germany
    • France
    • Italy
    • Spain
    • Russia
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • Australia
    • Southeast Asia
    • Rest of Asia Pacific
  • Latin America
    • Brazil
    • Mexico
    • Rest of Latin America
  • Middle East and Africa
    • Saudi Arabia
    • South Africa
    • UAE
    • Rest of Middle East and Africa

Table of Contents

  1. Preface
    • Report Description and Scope
    • Research Scope
  2. Research Methodology
    • Research Methodology
      • Market Research Process
      • Primary Research
      • Secondary Research
    • Models
      • Company Share Analysis Model
      • Revenue Based Model
    • Research limitations
  3. Executive Summary
    • Global Market Overview and Executive Summary 2016 - 2027 (USD Million)
    • Market Snapshot
  4. Market Dynamics and Industry Analysis
    • Global Real World Evidence Solutions Market: Introduction
    • Market Drivers
    • Market Restraint
    • Market Opportunity
    • Porter’s Five Forces Analysis
  5. Trending Insights on Current Market Scenario
    • Current Market Trends
    • SWOT Analysis
    • PESTEL Analysis
  6. Market Growth Attractiveness Analysis
    • Growth Attractiveness Analysis
      • By Component
      • By Therapeutic Area
      • By End User
      • By Region
  1. Competitive Share Analysis
    • Company Share Analysis
      • Global Real World Evidence Solutions Market: Company Market Share, 2019
    • Strategic Developments
      • Mergers and Acquisitions
      • New Product Launches
      • Partnerships, Collaborations and Joint Ventures
  1. Global Real World Evidence Solutions Market: Component Segment Analysis
    • Introduction
      • Market Revenue Share, by Component, 2019 & 2027
      • Component Revenue Estimates and Forecast, 2016 - 2027 (USD Million)
  1. Global Real World Evidence Solutions Market: Therapeutic Area Segment Analysis
    • Introduction
      • Market Revenue Share, by Therapeutic Area, 2019 & 2027
      • Therapeutic Area Revenue Estimates and Forecast, 2016 - 2027 (USD Million)
  1. Global Real World Evidence Solutions Market: End User Segment Analysis
    • Introduction
      • Market Revenue Share, by End User, 2019 & 2027
      • End User Revenue Estimates and Forecast, 2016 - 2027 (USD Million)
  1. Global Real World Evidence Solutions Market: Regional Analysis
    • Regional Overview
      • Market Revenue Share, by Region, 2019 & 2027
      • Market Revenue Estimates and Forecast, by Region, 2016 - 2027 (USD Million)
    • North America
      • Market Revenue Estimates and Forecast, 2016 - 2027 (USD Million)
      • By Country
      • By Component
      • By Therapeutic Area
      • By End User
      • US Market Revenue Estimates and Forecast, 2016 - 2027 (USD Million)
        • By Component
        • By Therapeutic Area
        • By End User
      • Canada Market Revenue Estimates and Forecast, 2016 - 2027 (USD Million)
        • By Component
        • By Therapeutic Area
        • By End User
      • Rest of North America Market Revenue Estimates and Forecast, 2016 - 2027 (USD Million)
        • By Component
        • By Therapeutic Area
        • By End User
    • Europe
      • Market Revenue Estimates and Forecast, 2016 - 2027 (USD Million)
      • By Country
      • By Component
      • By Therapeutic Area
      • By End User
      • Germany Market Revenue Estimates and Forecast, 2016 - 2027 (USD Million)
        • By Component
        • By Therapeutic Area
        • By End User
      • UK Market Revenue Estimates and Forecast, 2016 - 2027 (USD Million)
        • By Component
        • By Therapeutic Area
        • By End User
      • France Market Revenue Estimates and Forecast, 2016 - 2027 (USD Million)
        • By Component
        • By Therapeutic Area
        • By End User
      • Italy Market Revenue Estimates and Forecast, 2016 - 2027 (USD Million)
        • By Component
        • By Therapeutic Area
        • By End User
      • Spain Market Revenue Estimates and Forecast, 2016 - 2027 (USD Million)
        • By Component
        • By Therapeutic Area
        • By End User
      • Russia Market Revenue Estimates and Forecast, 2016 - 2027 (USD Million)
        • By Component
        • By Therapeutic Area
        • By End User
      • Rest of Europe Market Revenue Estimates and Forecast, 2016 - 2027 (USD Million)
        • By Component
        • By Therapeutic Area
        • By End User
    • Asia Pacific
      • Market Revenue Estimates and Forecast, 2016 - 2027 (USD Million)
      • By Country
      • By Component
      • By Therapeutic Area
      • By End User
      • China Market Revenue Estimates and Forecast, 2016 - 2027 (USD Million)
        • By Component
        • By Therapeutic Area
        • By End User
      • Japan Market Revenue Estimates and Forecast, 2016 - 2027 (USD Million)
        • By Component
        • By Therapeutic Area
        • By End User
      • India Market Revenue Estimates and Forecast, 2016 - 2027 (USD Million)
        • By Component
        • By Therapeutic Area
        • By End User
      • Australia Market Revenue Estimates and Forecast, 2016 - 2027 (USD Million)
        • By Component
        • By Therapeutic Area
        • By End User
      • Southeast Asia Market Revenue Estimates and Forecast, 2016 - 2027 (USD Million)
        • By Component
        • By Therapeutic Area
        • By End User
      • Rest of Asia Pacific Market Revenue Estimates and Forecast, 2016 - 2027 (USD Million)
        • By Component
        • By Therapeutic Area
        • By End User
    • Latin America Market Revenue Estimates and Forecast, 2016 - 2027 (USD Million)
      • By Country
      • By Component
      • By Therapeutic Area
      • By End User
      • Brazil Market Revenue Estimates and Forecast, 2016 - 2027 (USD Million)
        • By Component
        • By Therapeutic Area
        • By End User
      • Mexico Market Revenue Estimates and Forecast, 2016 - 2027 (USD Million)
        • By Component
        • By Therapeutic Area
        • By End User
      • Rest of Latin America Market Revenue Estimates and Forecast, 2016 - 2027 (USD Million)
        • By Component
        • By Therapeutic Area
        • By End User
    • Middle East and Africa
      • Market Revenue Estimates and Forecast, 2016 - 2027 (USD Million)
      • By Country
      • By Component
      • By Therapeutic Area
      • By End User
      • Saudi Arabia Market Revenue Estimates and Forecast, 2016 - 2027 (USD Million)
        • By Component
        • By Therapeutic Area
        • By End User
      • South Africa Market Revenue Estimates and Forecast, 2016 - 2027 (USD Million)
        • By Component
        • By Therapeutic Area
        • By End User
      • UAE Market Revenue Estimates and Forecast, 2016 - 2027 (USD Million)
        • By Component
        • By Therapeutic Area
        • By End User
      • Rest of Middle East and Africa Market Revenue Estimates and Forecast, 2016 - 2027 (USD Million)
        • By Component
        • By Therapeutic Area
        • By End User
  1. Company Profiles
    • Company profile section covers below data points
      • Company Overview
      • Financial Overview
      • Product Portfolio
      • Business Strategy
      • Recent Developments
    • Companies mentioned in the report are

      IQVIA (US), International Business Machines Corporation (US), ICON (Ireland), PAREXEL (US), Pharmaceutical Product Development (US), Optum (US), Cognizant (US), Oracle (US), SAS (US), Syneos Health (US), Anthem (US), Clinigen Group (UK), Palantir Technologies (UK), and Flatiron Health (US).

  2. Market Effect Factor Analysis
  3. Report Conclusion

List of Figures

  1. Global Real World Evidence Solutions Market Revenue Estimates and Forecast, 2016 - 2027 (USD Million)
  2. Porter’s Five Forces Analysis
  3. SWOT Analysis
  4. PESTEL Analysis
  5. Company Share Analysis, 2019
  6. Market Revenue Share Analysis, by Component, 2019 & 2027
  7. Market Revenue Share Analysis, by Therapeutic Area, 2019 & 2027
  8. Market Revenue Share Analysis, by End User, 2019 & 2027
  9. Market Revenue Share Analysis, by Region, 2019 & 2027
  10. North America Market Revenue Estimates and Forecast, 2016 - 2027 (USD Million)
  11. Europe Market Revenue Estimates and Forecast, 2016 - 2027 (USD Million)
  12. Asia Pacific Market Revenue Estimates and Forecast, 2016 - 2027 (USD Million)
  13. Latin America Market Revenue Estimates and Forecast, 2016 - 2027 (USD Million)
  14. Middle East and Africa Market Revenue Estimates and Forecast, 2016 - 2027 (USD Million)

List of Tables

  1. Global Real World Evidence Solutions Market: Snapshot
  2. Market Growth Drivers: Impact Analysis
  3. Market Restraints: Impact Analysis
  4. Global Market Revenue Estimates and Forecast, by Region, 2016 - 2027 (USD Million)
  5. Global Market Revenue Estimates and Forecast, By Component, 2016 - 2027 (USD Million)
  6. Global Market Revenue Estimates and Forecast, By Therapeutic Area, 2016 - 2027 (USD Million)
  7. Global Market Revenue Estimates and Forecast, By End User, 2016 - 2027 (USD Million)
  8. North America Market Size Analysis, 2016 - 2027 (USD Million)
  9. North America Market Size Analysis, 2016 - 2027 (USD Million), By Country
  10. North America Market Size Analysis, 2016 - 2027 (USD Million), By Component
  11. North America Market Size Analysis, 2016 - 2027 (USD Million), By Therapeutic Area
  12. North America Market Size Analysis, 2016 - 2027 (USD Million), By End User
  13. US Market Size Analysis, 2016 - 2027 (USD Million)
  14. US Market Size Analysis, 2016 - 2027 (USD Million), By Component
  15. US Market Size Analysis, 2016 - 2027 (USD Million), By Therapeutic Area
  16. US Market Size Analysis, 2016 - 2027 (USD Million), By End User
  17. Canada Market Size Analysis, 2016 - 2027 (USD Million)
  18. Canada Market Size Analysis, 2016 - 2027 (USD Million), By Component
  19. Canada Market Size Analysis, 2016 - 2027 (USD Million), By Therapeutic Area
  20. Canada Market Size Analysis, 2016 - 2027 (USD Million), By End User
  21. Rest of North America Market Size Analysis, 2016 - 2027 (USD Million)
  22. Rest of North America Market Size Analysis, 2016 - 2027 (USD Million), By Component
  23. Rest of North America Market Size Analysis, 2016 - 2027 (USD Million), By Therapeutic Area
  24. Rest of North America Market Size Analysis, 2016 - 2027 (USD Million), By End User
  25. Europe Market Size, by Country, 2016 - 2027 (USD Million)
  26. Europe Market Size, By Component, 2016 - 2027 (USD Million)
  27. Europe Market Size, By Therapeutic Area, 2016 - 2027 (USD Million)
  28. Europe Market Size, By End User, 2016 - 2027 (USD Million)
  29. Germany Market Size Analysis, 2016 - 2027 (USD Million)
  30. Germany Market Size Analysis, 2016 - 2027 (USD Million), By Component
  31. Germany Market Size Analysis, 2016 - 2027 (USD Million), By Therapeutic Area
  32. Germany Market Size Analysis, 2016 - 2027 (USD Million), By End User
  33. UK Market Size Analysis, 2016 - 2027 (USD Million)
  34. UK Market Size Analysis, 2016 - 2027 (USD Million), By Component
  35. UK Market Size Analysis, 2016 - 2027 (USD Million), By Therapeutic Area
  36. UK Market Size Analysis, 2016 - 2027 (USD Million), By End User
  37. France Market Size Analysis, 2016 - 2027 (USD Million)
  38. France Market Size Analysis, 2016 - 2027 (USD Million), By Component
  39. France Market Size Analysis, 2016 - 2027 (USD Million), By Therapeutic Area
  40. France Market Size Analysis, 2016 - 2027 (USD Million), By End User
  41. Italy Market Size Analysis, 2016 - 2027 (USD Million)
  42. Italy Market Size Analysis, 2016 - 2027 (USD Million), By Component
  43. Italy Market Size Analysis, 2016 - 2027 (USD Million), By Therapeutic Area
  44. Italy Market Size Analysis, 2016 - 2027 (USD Million), By End User
  45. Spain Market Size Analysis, 2016 - 2027 (USD Million)
  46. Spain Market Size Analysis, 2016 - 2027 (USD Million), By Component
  47. Spain Market Size Analysis, 2016 - 2027 (USD Million), By Therapeutic Area
  48. Spain Market Size Analysis, 2016 - 2027 (USD Million), By End User
  49. Russia Market Size Analysis, 2016 - 2027 (USD Million)
  50. Russia Market Size Analysis, 2016 - 2027 (USD Million), By Component
  51. Russia Market Size Analysis, 2016 - 2027 (USD Million), By Therapeutic Area
  52. Russia Market Size Analysis, 2016 - 2027 (USD Million), By End User
  53. Rest of Europe Market Size Analysis, 2016 - 2027 (USD Million)
  54. Rest of Europe Market Size Analysis, 2016 - 2027 (USD Million), By Component
  55. Rest of Europe Market Size Analysis, 2016 - 2027 (USD Million), By Therapeutic Area
  56. Rest of Europe Market Size Analysis, 2016 - 2027 (USD Million), By End User
  57. Asia Pacific Market Size Analysis, 2016 - 2027 (USD Million)
  58. Asia Pacific Market Size Analysis, 2016 - 2027 (USD Million), By Country
  59. Asia Pacific Market Size Analysis, 2016 - 2027 (USD Million), By Component
  60. Asia Pacific Market Size Analysis, 2016 - 2027 (USD Million), By Therapeutic Area
  61. Asia Pacific Market Size Analysis, 2016 - 2027 (USD Million), By End User
  62. China Market Size Analysis, 2016 - 2027 (USD Million)
  63. China Market Size Analysis, 2016 - 2027 (USD Million), By Component
  64. China Market Size Analysis, 2016 - 2027 (USD Million), By Therapeutic Area
  65. China Market Size Analysis, 2016 - 2027 (USD Million), By End User
  66. Japan Market Size Analysis, 2016 - 2027 (USD Million)
  67. Japan Market Size Analysis, 2016 - 2027 (USD Million), By Component
  68. Japan Market Size Analysis, 2016 - 2027 (USD Million), By Therapeutic Area
  69. Japan Market Size Analysis, 2016 - 2027 (USD Million), By End User
  70. India Market Size Analysis, 2016 - 2027 (USD Million)
  71. India Market Size Analysis, 2016 - 2027 (USD Million), By Component
  72. India Market Size Analysis, 2016 - 2027 (USD Million), By Therapeutic Area
  73. India Market Size Analysis, 2016 - 2027 (USD Million), By End User
  74. Australia Market Size Analysis, 2016 - 2027 (USD Million)
  75. Australia Market Size Analysis, 2016 - 2027 (USD Million), By Component
  76. Australia Market Size Analysis, 2016 - 2027 (USD Million), By Therapeutic Area
  77. Australia Market Size Analysis, 2016 - 2027 (USD Million), By End User
  78. Southeast Asia Market Size Analysis, 2016 - 2027 (USD Million)
  79. Southeast Asia Market Size Analysis, 2016 - 2027 (USD Million), By Component
  80. Southeast Asia Market Size Analysis, 2016 - 2027 (USD Million), By Therapeutic Area
  81. Southeast Asia Market Size Analysis, 2016 - 2027 (USD Million), By End User
  82. Rest of Asia Pacific Market Size Analysis, 2016 - 2027 (USD Million)
  83. Rest of Asia Pacific Market Size Analysis, 2016 - 2027 (USD Million), By Component
  84. Rest of Asia Pacific Market Size Analysis, 2016 - 2027 (USD Million), By Therapeutic Area
  85. Rest of Asia Pacific Market Size Analysis, 2016 - 2027 (USD Million), By End User
  86. Latin America Market Size Analysis, 2016 - 2027 (USD Million)
  87. Latin America Market Size Analysis, 2016 - 2027 (USD Million), By Country
  88. Latin America Market Size Analysis, 2016 - 2027 (USD Million), By Component
  89. Latin America Market Size Analysis, 2016 - 2027 (USD Million), By Therapeutic Area
  90. Latin America Market Size Analysis, 2016 - 2027 (USD Million), By End User
  91. Brazil Market Size Analysis, 2016 - 2027 (USD Million)
  92. Brazil Market Size Analysis, 2016 - 2027 (USD Million), By Component
  93. Brazil Market Size Analysis, 2016 - 2027 (USD Million), By Therapeutic Area
  94. Brazil Market Size Analysis, 2016 - 2027 (USD Million), By End User
  95. Mexico Market Size Analysis, 2016 - 2027 (USD Million)
  96. Mexico Market Size Analysis, 2016 - 2027 (USD Million), By Component
  97. Mexico Market Size Analysis, 2016 - 2027 (USD Million), By Therapeutic Area
  98. Mexico Market Size Analysis, 2016 - 2027 (USD Million), By End User
  99. Rest of Latin America Market Size Analysis, 2016 - 2027 (USD Million)
  100. Rest of Latin America Market Size Analysis, 2016 - 2027 (USD Million), By Component
  101. Rest of Latin America Market Size Analysis, 2016 - 2027 (USD Million), By Therapeutic Area
  102. Rest of Latin America Market Size Analysis, 2016 - 2027 (USD Million), By End User
  103. Middle East and Africa Market Size Analysis, 2016 - 2027 (USD Million)
  104. Middle East and Africa Market Size Analysis, 2016 - 2027 (USD Million), By Country
  105. Middle East and Africa Market Size Analysis, 2016 - 2027 (USD Million), By Component
  106. Middle East and Africa Market Size Analysis, 2016 - 2027 (USD Million), By Therapeutic Area
  107. Middle East and Africa Market Size Analysis, 2016 - 2027 (USD Million), By End User
  108. Saudi Arabia Market Size Analysis, 2016 - 2027 (USD Million)
  109. Saudi Arabia Market Size Analysis, 2016 - 2027 (USD Million), By Component
  110. Saudi Arabia Market Size Analysis, 2016 - 2027 (USD Million), By Therapeutic Area
  111. Saudi Arabia Market Size Analysis, 2016 - 2027 (USD Million), By End User
  112. South Africa Market Size Analysis, 2016 - 2027 (USD Million)
  113. South Africa Market Size Analysis, 2016 - 2027 (USD Million), By Component
  114. South Africa Market Size Analysis, 2016 - 2027 (USD Million), By Therapeutic Area
  115. South Africa Market Size Analysis, 2016 - 2027 (USD Million), By End User
  116. UAE Market Size Analysis, 2016 - 2027 (USD Million)
  117. UAE Market Size Analysis, 2016 - 2027 (USD Million), By Component
  118. UAE Market Size Analysis, 2016 - 2027 (USD Million), By Therapeutic Area
  119. UAE Market Size Analysis, 2016 - 2027 (USD Million), By End User
  120. Rest of Middle East and Africa Market Size Analysis, 2016 - 2027 (USD Million)
  121. Rest of Middle East and Africa Market Size Analysis, 2016 - 2027 (USD Million), By Component
  122. Rest of Middle East and Africa Market Size Analysis, 2016 - 2027 (USD Million), By Therapeutic Area
  123. Rest of Middle East and Africa Market Size Analysis, 2016 - 2027 (USD Million), By End User

Payment Details